Simplify Logo

Full-Time

Associate Director

Clinical Contracts

Posted on 6/27/2024

Vir Biotechnology

Vir Biotechnology

501-1,000 employees

Develops treatments for infectious diseases

Biotechnology
Healthcare

Compensation Overview

$168.5k - $246.5kAnnually

Expert

San Francisco, CA, USA

Requires onsite presence in San Francisco, California for a few days each week.

Category
Contract Management
Legal & Compliance
Required Skills
Word/Pages/Docs
PowerPoint/Keynote/Slides
Requirements
  • BS/MS and 12+ years’ experience in the pharmaceutical or life sciences industry
  • Extensive experience in clinical contract negotiations
  • Knowledge of relevant local regulations
  • Experience providing contract support at several stages of clinical trials
  • Advanced knowledge of Microsoft Word, Excel, and PowerPoint
  • Familiarity with eSignature software including DocuSign and Adobe Acrobat Sign
Responsibilities
  • Direct negotiation, and oversight of negotiations, of clinical trial agreements
  • End-to-end management of the clinical trial agreement (CTA) process and strategy for global, multi-site clinical trials
  • Draft and review Letters of Authorization, Powers of Attorney, Material Transfer Agreements, and other development agreements
  • Review established templates for clinical trial agreements and other development agreements
  • Collaborate regularly with Legal for contract approval, execution, and risk assessment
  • Co-manage the external partnership with the site contract and budget functional service provider

Vir Biotechnology is at the forefront of combating infectious diseases, leveraging advanced technologies such as a proprietary monoclonal antibody platform along with machine learning and artificial intelligence. This focus not only prioritizes public health but also fosters a culture of continuous innovation and commitment to scientific excellence. Working here means contributing to pivotal developments that address some of the most pressing global health challenges today, such as influenza, HIV, and COVID-19, in an environment that values cutting-edge research and a collaborative spirit.

Company Stage

Grant

Total Funding

$908.6M

Headquarters

San Francisco, California

Founded

2016

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent bullish quarterly reports and increased analyst estimates suggest strong financial performance.
  • Significant investments, such as the $214,000 from Diversified Trust Co, indicate confidence in Vir's future prospects.
  • Presentations at high-profile conferences like J.P. Morgan's Annual Healthcare Conference and AASLD's The Liver Meeting® enhance Vir's visibility and credibility in the biotech community.

What critics are saying

  • Recent layoffs and facility shutdowns indicate potential financial instability and operational challenges.
  • The resignation of key executives, including the CFO and Chief Medical Officer, could lead to strategic and leadership uncertainties.

What makes Vir Biotechnology unique

  • Vir Biotechnology's focus on leveraging immunology expertise to engineer human antibodies into powerful medicines sets it apart from competitors.
  • Their rapid growth, as evidenced by being ranked the fastest-growing company in North America on the 2023 Deloitte Technology Fast 500, highlights their market impact.
  • Vir's ongoing Phase 2 trials for chronic hepatitis delta and B demonstrate their commitment to addressing unmet medical needs with innovative therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Comprehensive healthcare coverage

Employer matched 401(k)

Employee stock purchase plan

Childcare assistance

Tuition reimbursement

INACTIVE